Skip to main content
. 2020 Oct 15;10(5):266–282.

Figure 4.

Figure 4

Treatments received by COVID-19 patients. A. 65% of COVID-19 patients received pharmacological treatments and TaibUVID nutritional supplements. 35% of COVID-19 patients received TaibUVID nutritional supplements only. B. 65% of COVID-19 patients received TaibUVID inhalation therapy. C. 70% of COVID-19 patients improved in 1-4 days, 25% improved in 5-10 days while 5% improved in more than 10 days. D. 70% of COVID-19 contacts (on regular TaibUVID supplements intake) did not catch COVID-19 infection. 30% of COVID-19 contacts (on non-regular TaibUVID supplements intake) caught COVID-19 infection. Symptoms of 2 out of those 6 contacts rapidly disappeared (without performing PCR) upon starting regular TaibUVID intake. 5 out of those 6 contacts (25%) got dramatic rapid disappearance of symptoms upon regular TaibUVID intake. One case (5%) was sever and improved in hospital (using pharmacological treatments and TaibUVID nutritional supplements).